VEGFC and neoplasm: In contrast to VEGF-C, antagonism of VEGF-A in the intervention setting did not reduce tumor-associated lymphatic remodeling nor metastatic spread in our model of adjuvant therapy, though disease associated vessel enlargement was reduced, likely due to decreased mechanical induction by lymph pressure [48], [52], [53].